|
STRADB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.64750000000813E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25069999999494E-05 |
| Normal-vs-Stage2 |
4.839500E-04 |
| Normal-vs-Stage3 |
1.196200E-03 |
| Normal-vs-Stage4 |
2.192900E-04 |
| Stage1-vs-Stage2 |
5.300000E-01 |
| Stage1-vs-Stage3 |
7.159600E-01 |
| Stage1-vs-Stage4 |
8.320400E-01 |
| Stage2-vs-Stage3 |
4.430000E-01 |
| Stage2-vs-Stage4 |
6.759800E-01 |
| Stage3-vs-Stage4 |
6.258600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90239999997566E-06 |
| Normal-vs-AfricanAmerican |
6.796800E-03 |
| Normal-vs-Asian |
2.560800E-01 |
| Caucasian-vs-AfricanAmerican |
7.340200E-01 |
| Caucasian-vs-Asian |
7.264400E-01 |
| AfricanAmerican-vs-Asian |
8.631600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.48529999971703E-07 |
| Normal-vs-Female |
4.496100E-02 |
| Male-vs-Female |
3.23189999995588E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.462670E-03 |
| Normal-vs-Age(41-60Yrs) |
4.18509999999817E-05 |
| Normal-vs-Age(61-80Yrs) |
1.50631999999984E-05 |
| Normal-vs-Age(81-100Yrs) |
3.471000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.764000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.358200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.170200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.881200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.437600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.089840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.358780E-01 |
| Normal-vs-Grade 2 |
1.425000E-04 |
| Normal-vs-Grade 3 |
5.8703999999965E-05 |
| Normal-vs-Grade 4 |
2.47179999999236E-05 |
| Grade 1-vs-Grade 2 |
7.483200E-01 |
| Grade 1-vs-Grade 3 |
7.380200E-01 |
| Grade 1-vs-Grade 4 |
3.576000E-01 |
| Grade 2-vs-Grade 3 |
9.498200E-01 |
| Grade 2-vs-Grade 4 |
2.624400E-01 |
| Grade 3-vs-Grade 4 |
2.073800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.154110E-02 |
| Normal-vs-ccB subtype |
1.47269999994926E-06 |
| ccA subtype-vs-ccB subtype |
3.204700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.958700E-04 |
| Normal-vs-N1 |
3.319300E-03 |
| N0-vs-N1 |
1.840230E-01 |
|
|
